ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO299

Low Expression of Renal Claudin-2 Increases Medullary Pro-Inflammatory Macrophages and Calcification in Nephrectomy Patients with a History of Urinary Stone Disease

Session Information

Category: Bone and Mineral Metabolism

  • 502 Bone and Mineral Metabolism: Clinical

Authors

  • Jayachandran, Muthuvel, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, United States
  • Delbusso, Miles, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, United States
  • Herrera Hernandez, Loren Paola, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, United States
  • Haskic, Zejfa, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, United States
  • Rule, Andrew D., Mayo Clinic College of Medicine and Science, Rochester, Minnesota, United States
  • Koo, Kevin, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, United States
  • Lieske, John C., Mayo Clinic College of Medicine and Science, Rochester, Minnesota, United States
Background

The transmembrane protein claudin-2 (Clnd2) is highly expressed in the proximal tubule and descending thin limb where it is key for ~70% of filtered Ca2+ reabsorption. Men with a rare missense mutation in Clnd2 manifest hypercalciuria and urinary stone disease (USD). However, the relationship of Clnd2 expression to renal calcification and interstitial cellular responses is not known. Thus, we examined Cldn2 expression, interstitial calcification, and pro- and anti-inflammatory macrophages (Mφ’s) in nephrectomy samples from patients with and without a USD history.

Methods

Non-cancerous kidney tissue sections from patients with (n=31 stone formers (SFs); 10F/21M) and without (n=50 non-stone formers (NSFs); 16F/34M) a history of USD were used for immunohistochemical analyses. Data are presented as median (25th, 75th percentile) and analyzed by Wilcoxon rank-sum test to identify statistically significant (P<0.05) differences between groups.

Results

Expression of Clnd2 protein in both cortex and medulla of kidneys was significantly (P=0.02) lower in SFs than NSFs. Renal medullary calcification (% calcification) and populations of M1 Mφ’s (proinflammatory) were significantly (p<0.001) greater in SFs. There were no differences in the renal tissue population of M2 Mφ’s (anti-inflammatory), age, body mass index, hypertension before surgery, serum creatinine, and eGFR between groups.

Conclusion

These results suggest that SFs have decreased expression of Clnd2 protein in the proximal tubule and thin descending limb of Henle’s loop. This in turn may increase the formation of interstitial calcifications and populations of pro-inflammatory Mφ’s in USD formers. NIDDK (DK135097) and Mayo Foundation.

Funding

  • NIDDK Support